Screener
Vaxcyte, Inc. PCVX SWITZERLAND — PP&E (Net)
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Vaxcyte, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 4:12 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001649094-26-000017
Our long-lived assets are based in the United States and Switzerland. Long-lived assets are comprised of property and equipment. As of March 31, 2026 and December 31, 2025, property and equipment based in the United States was $41.3 million and $39.7 million, respectively. As of March 31, 2026 and December 31, 2025, property and equipment based in Switzerland was $219.4 million and $217.7 million, respectively.
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Vaxcyte, Inc.'s SWITZERLAND — PP&E (net)?
- Vaxcyte, Inc. (PCVX) reported SWITZERLAND — PP&E (net) of $219.4M in Q1 2026.
- How has Vaxcyte, Inc.'s SWITZERLAND — PP&E (net) changed year-over-year?
- Vaxcyte, Inc.'s SWITZERLAND — PP&E (net) increased by 24.2% year-over-year, from $176.6M to $219.4M.
- What does SWITZERLAND — PP&E (net) mean?
- This metric represents the net book value of tangible assets, such as laboratory facilities, manufacturing equipment, and specialized infrastructure, located within the Swiss geographic segment. It reflects the company's capital investment in regional operational capacity and long-term physical assets used to support research, development, or production activities. Monitoring this balance helps investors assess the scale of physical footprint and the intensity of capital deployment in this specific international jurisdiction.
Ask your AI about Vaxcyte, Inc.'s switzerland — pp&e (net).
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude